Israel's miracle vaccine is the most successful in the world, the Covid-19 vaccine alliance COVAX

These are really promising results, especially when the world is hoping for a vaccine capable of ending the epidemic, in the context of a new strain emerging. "Although still cautious, it can be said that miracles are happening," said Eran Segal, an expert from the Weizmann Institute.

With the expectation of controlling and ending the Covid-19 pandemic, a global Covid-19 vaccine alliance was born (called COVAX) with more than 100 participating countries. COVAX's goal is to distribute about 2 billion doses of vaccine worldwide by the end of 2021, with healthcare workers first, then about 20% of those most vulnerable to the disease. in each Member State, regardless of income.

Therefore, COVAX is considered as a great motivation for the global deployment of many safe and effective vaccines, the best "shot" at the end of the Covid-19 pandemic, which makes sense. very important in the fight against the new corona virus. The number of Covid-19 vaccines is currently a scarce and finite resource.

However, in Israel's rapid vaccination campaign, having the right amount of vaccine is not the only key. In the vaccine economy of the 21st century, data is also power.

Israel sets up vaccination plans for its people a few months earlier than larger and wealthier countries, and both places orders early and shares patient information after vaccinations to monitor vaccine effectiveness. please for each case. As a result, Israel soon got the necessary Covid-19 vaccine to protect its people faster than anywhere else.

A healthcare system with high-tech applications and extremely effective vaccine deployment and rapid response to vaccine manufacturers, helping to accelerate the global production and vaccination process.

Less than a month after vaccination began on December 19 last year, using a vaccine developed by Pfizer and BioNtech, with a rate of about 150,000 people per day, more than 20% of the population in Israel has already been vaccinated. received the first dose of this 2-shot vaccine. In addition, more than 70% of people aged 60 and over or those in priority vaccination status are also vaccinated, reaching the highest rate in the world.

Notably, the level of corona infection even before the second dose of the vaccine was also significantly reduced. Israeli Prime Minister Benyamin Netnayahu affirmed that the repository of information to track vaccine effectiveness will help countries develop strategies to end the outbreak of the pandemic.

Israel contacts priority vaccination recipients through its health care system. By law, all residents of this country must register with an accredited medical facility. Israelis just need to visit their (healthcare provider) website and they will instantly know if they are eligible.

"I think it's amazing that within two to three weeks Israel has collected data from hundreds of thousands of people," said immunologist Cyrille Cohen, a member of the Israeli Ministry of Health's advisory committee on vaccines. This could help answer important questions regarding the immediate protective effects of a single dose of vaccine."

The data shows that the rate of infection in Israel is slowing down compared to the peak of the epidemic in January 2021, although the number of infections in recent days is somewhat worrying. But not yet, the number of people with severe symptoms has also decreased - mainly over the age of 60, which is also the earliest group of people to be vaccinated due to the high risk.

Maccabi Health Organization - one of 4 health organizations (HMOs) in Israel has tracked 163,000 people who received 2 doses of the vaccine. Only 31 of them were positive for Covid-19, while the unvaccinated group had up to 6,500 infected. Another survey conducted by the Israeli Ministry of Health with a broader scale showed that only 537 cases out of a total of 750,000 people injected were positive for Covid-19 - accounting for 0.07%. Of these, 38 had to be hospitalized with symptoms ranging from normal to severe.

These are really promising results, especially when the world is hoping for a vaccine capable of ending the epidemic, in the context of a new strain emerging. "Although still cautious, it can be said that miracles are happening," said Eran Segal, an expert from the Weizmann Institute.

However, experts are still wary that there is still a very long way to go. Experts say the number of serious infections is decreasing, but the total number of infections is not disappearing as quickly. In addition, research results will change as new strains gradually appear.

What happened in Israel seems to be a lesson in how rapid vaccination works, but it is also the beginning of a new challenge for the global immunization program.

Miracle in a country no one expected

An undeniable advantage is that Israel is a relatively small country, so the effectiveness of the vaccine can be passed on by word of mouth. While prioritizing groups over 60 and healthcare workers, their policy is "no waste". That is, if there is a spare vaccine for the day or week, they are ready to give it to anyone, from the pizza delivery worker to the student waiting for the bus.

"Our vaccine campaign is well-prepared, but at the same time very flexible," said Hagai Levine, an epidemiologist from Hebrew University. "When it comes to planning, there's going to be random elements that need to be changed quickly. And we do it very well."

Prime Minister Benjamin Netanyahu announced that by the end of March, the entire population of Israel would be vaccinated. For experts, it is possible, but it will not be so simple.

The whole world is looking forward to it

The Israeli data showed that the vaccine worked on an individual level, then compared with people who had not been vaccinated. The country's health system makes it easy for them to do so.

But not only that, this system also brings a huge support to the world vaccine race. In the context of insufficient supply, Israel has easy access to the vaccine due to the promise of rapid data delivery to Pfizer, which is still monitoring the effectiveness and side effects of the drug.

However, experts say the situation will gradually become more complicated, especially when it comes to achieving the so-called "herd immunity". Due to the emergence of new strains, it is very likely that the virus will be resistant to the vaccine. At the moment, the evidence shows that the current vaccine is effective against the new strain, but this could completely change in the future.

There are many more questions. Brian Wahl, an epidemiologist from Johns Hopkins University, said that even if the vaccine proves to be effective, they still have to continue to study its effects against the ability of the disease to spread. Or more specifically, whether a person who is vaccinated can transmit the disease or not.

Another important question is how long the vaccine lasts. "We need to continue to monitor vaccine protection over the next few months," Wahl said.

Plus, this is still a new vaccine, so not everyone is excited about it. There are still people who carry prejudices, hesitate to vaccinate, and getting them to accept vaccination is a challenge that Israel and many other countries face.

At the moment, only people aged 16 and over have access to the vaccine. Scientists also don't know when children will be approved for vaccinations. All of this creates a loophole where a part of the population is not vaccinated and becomes a potential outbreak for the spread of the virus. "Once 100% of the population is vaccinated, that's one thing. But if not, things get very complicated." Bruce Rosen, director of the Smokler Center for Health Policy Research at the Myers-JDC-Brookdale (MJB) Institute in Jerusalem.

9 more people infected with COVID-19 | New cases of infection in Hanoi went to markets, shopping centers team youtuber11:02:52 29/01/2021In the morning of January 28, Hanoi recorded 1 new case of Covid-19 in the community. Patient 1581 is Mrs. LTMT born in 1967, living at P12A05 T6 Times City urban area, Vinh Tuy ward, Hai Ba Trung district. Patient 1581 (patient 1581) is epidemiologically related to the previous case, patient 1553. Travel...